Exploring targets of TET2-mediated methylation reprogramming as potential discriminators of prostate cancer progression

Global DNA methylation alterations are hallmarks of cancer. The tumor-suppressive TET enzymes, which are involved in DNA demethylation, are decreased in prostate cancer (PCa); in particular, TET2 is specifical...
Source: Clinical Epigenetics - Category: Research Authors: Tags: Research Source Type: research